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We are delighted to launch the Journal of Molecular 
and Genetic Medicine. This provides an opportunity 
to showcase biomedical research from the developing 
world and the health issues affecting these regions. 
The aim of the journal is to make science from all 
areas of the globe freely accessible via open access 
publishing. 
 
A vast number of journals are published monthly but 
a large percentage is only available by subscription 
and many libraries in developing nations cannot af-
ford the institutional fees. The costs of publishing an 
article can be prohibitive for struggling laboratories 
that have to decide whether to invest in reagents or 
paper.  Budget  constraints  also  prevent  researchers 
from  attending  large  European  or  US  meetings  to 
showcase their work and the scientific community as 
a whole loses out; valuable data generated by smaller 
academic laboratories in developing countries is not 
shared. 
 
The  global  scientific  community  can  be  brought 
closer  together  through  web-based  communications 
and  open-access  publishing  provides  inexpensive 
worldwide exposure and publicity of the work which 
may not be made available otherwise. This approach 
has been endorsed by both the Wellcome Trust (UK) 
and the National Institute of Health (US).  
 
We hope that publishing in the Journal of Molecular 
and  Genetic  Medicine  will  increase  awareness  of 
studies in developing countries and foster collabora-
tions with better funded European and US research 
communities. The pharmaceutical industry is already 
thriving in developing nations due to low production 
and clinical trial costs. India is the fourth largest pro-
ducer of pharmaceuticals in the world and multina-
tionals such as GlaxoSmithKline, Pfizer, and Novar-
tis  have  set  up  laboratories  in  China.
  Science  and 
technology  drives  economic  growth  so  supporting 
grass  roots  research  and  cultivating  collaborations 
should provide new opportunities for scientists and 
slow the mass migration of talent from these regions. 
 
Understanding  the  molecular  and  genetic  basis  of 
disease is paramount in developing defences against 
them. We invite submissions from all areas of mo-
lecular  and  genetic  medicine  but  the  Journal  will 
give particular consideration to studies focussing on 
the health-related issues of developing nations such 
as malaria, HIV/AIDS, viral hepatitis, and microbial 
disease.  
 
The first issue of the Journal of Molecular and Ge-
netic Medicine includes articles on malaria, cardiac 
disease, and cancer. We hope this will be both a use-
ful resource and outlet for you and we look forward 
to receiving submissions from you in the future. 
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